{"DataElement":{"publicId":"2431554","version":"1","preferredName":"Nottingham Histopathologic Grade Nuclear Pleomorphism Integer","preferredDefinition":"A score indicating the degree or extent of variation in shape and size of the nuclei in an invasive breast carcinoma.","longName":"2431348v1.0:2432056v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431348","version":"1","preferredName":"Nottingham Score Nuclear Pleomorphism","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubulin formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index._definition pending","longName":"2431279v1.0:2431221v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431279","version":"1","preferredName":"Nottingham Score","preferredDefinition":"A numeric representation combining three histologic reporting elements, tubulin formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","longName":"C25595","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF1C9-10BC-3A91-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431221","version":"1","preferredName":"Nuclear Pleomorphism","preferredDefinition":"definition pending","longName":"C38721","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear Pleomorphism","conceptCode":"C38721","definition":"Having nuclei with various distinct forms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE306-FFB2-32FE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE00E1-AC4B-4092-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2432056","version":"1","preferredName":"Nuclear Pleomorphism Score Integer","preferredDefinition":"Nuclear Pleomorphism Score from 1 to 3. A score of 1 indicates small, regular nucleoli. A score of 2 indicates moderate increase in size of nuclei. A score of 3 indicates marked variation in size and nucleoli with chromatin clumping, etc._A number with no fractional part._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"2432056v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":"1","maxValue":"3","decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Small round nuclei","ValueMeaning":{"publicId":"2577189","version":"1","preferredName":"Small round nuclei","longName":"2577189","preferredDefinition":"Small round nuclei","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA92-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-53D5-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate increase in size, etc","ValueMeaning":{"publicId":"2577190","version":"1","preferredName":"Moderate increase in size, etc","longName":"2577190","preferredDefinition":"Moderate increase in size, etc","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA93-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-53D6-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"3","valueDescription":"Marked variation in size, nucleoli, chromatin clumping, etc","ValueMeaning":{"publicId":"2577188","version":"1","preferredName":"Marked variation in size, nucleoli, chromatin clumping, etc","longName":"2577188","preferredDefinition":"Marked variation in size, nucleoli, chromatin clumping, etc","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA91-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"062E16DD-53D7-16F1-E044-0003BA3F9857","beginDate":"2005-11-29","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-29","modifiedBy":"CROWLEYR","dateModified":"2005-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2434851","version":"1","preferredName":"Score Integer","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.:A number with no fractional part.","longName":"C25338:C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0643AECC-B7FB-298D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-30","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-30","modifiedBy":"ONEDATA","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"061284D5-189F-0705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-21","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-21","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000562","version":"1","longName":"edu.pitt.cabig.cae.domain.breast","context":"NCIP"}]},{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812063","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.breast","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.breast.NottinghamHistologicGrade.nuclearPleomorphism","type":"UML Qualified Attr","context":"NCIP"},{"name":"NottinghamHistologicGrade:nuclearPleomorphism","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.breast.NottinghamHistopathologicGrade.nuclearPleomorphism","type":"UML Qualified Attr","context":"NCIP"},{"name":"NottinghamHistopathologicGrade:nuclearPleomorphism","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Nuclear Pleomorphism","type":"Preferred Question Text","description":"Nuclear Pleomorphism","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE5421-F923-59F0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}